Ms Nadia Traficante
Project Manager
Department of Clinical Pathology
94 Scholarly works
3 Projects
HIGHLIGHTS
2026
Research grants (ARC, NHMRC, MRFF)
Driving Cancer Discoveries Through Integration of ‘Omics and Clinical Data
2026
Journal article
Real-world comparative outcomes of neoadjuvant chemotherapy with interval cytoreductive surgery versus primary cytoreductive surgery in epithelial ovarian cancer: insights from the australian ovarian cancer study (AOCS)
DOI: 10.1016/j.ijgc.2025.1030762026
Research grants (ARC, NHMRC, MRFF)
Identifying the Key to Treatment Resistance in Ovarian Cancer
2025
Other
Supplementary Data from Epithelial-to-Mesenchymal Transition Supports Ovarian Carcinosarcoma Tumorigenesis and Confers Sensitivity to Microtubule Targeting with Eribulin
DOI: 10.1158/0008-5472.306994012025
Other
Supplementary Data from Epithelial-to-Mesenchymal Transition Supports Ovarian Carcinosarcoma Tumorigenesis and Confers Sensitivity to Microtubule Targeting with Eribulin
DOI: 10.1158/0008-5472.306994042024
Journal article
BRCA1 secondary splice-site mutations drive exon-skipping and PARP inhibitor resistance
DOI: 10.1186/s12943-024-02048-12023
Research grants (ARC, NHMRC, MRFF)
Using Real World Data to Drive Cancer Care Research and Delivery
RECENT SCHOLARLY WORKS
2025
Journal article
Co-Amplification Of CCNE1 And AKT2 As Prognostic Biomarker And Therapeutic Target In Tubo-Ovarian High-Grade Serous Carcinoma
DOI: 10.1016/j.ijgc.2025.1016842024
Journal article
Immunological and molecular features of the tumor microenvironment of long-term survivors of ovarian cancer
DOI: 10.1172/JCI1795012024
Journal article
Proteogenomic analysis of enriched HGSOC tumor epithelium identifies prognostic signatures and therapeutic vulnerabilities
DOI: 10.1038/s41698-024-00519-82024
Journal article
Timing of whole genome duplication is associated with tumor-specific MHC-II depletion in serous ovarian cancer
DOI: 10.1038/s41467-024-50137-y2024
Journal article
Genome-wide association analyses of ovarian cancer patients undergoing primary debulking surgery identify candidate genes for residual disease
DOI: 10.1038/s41525-024-00395-y2024
Journal article
752P Clinical and molecular predictors of outcome in patients with tubo-ovarian high-grade serous carcinoma and exceptional survival
DOI: 10.1016/j.annonc.2024.08.813